Browse diseases

… substance co-use among AYAs who use tobacco, consistent across cancer history. Unlike previous research, alcohol co-use was associate…

…–45.4]; aHR 0.25 [95% CI 0.13–0.51]; p<0.001), particularly for hepatocellular carcinoma (aHR 0.13 [95% CI 0.05–0.36]). PWH with non–virus-related NADCs…

…rall quality of life (QoL) and health-related outcomes in older cancer patients with depression1 concluded that there is a dearth of l…

…vascular outcome or the most similar alternative. The composite chronic kidney disease outcome comprised end stage kidney disease, estimated glomerula…

…f interferon coordinate adaptive and innate immune responses to cancer immune checkpoint blockade. Cell. 2019;178(4):933–948.e14.Wong …

…) and negatively with digital ulcers (OR 0.4; CI 0.2-0.7). Lung cancer was associated with disease duration (OR 1.04; CI 1-1.08), smok…

… outweigh cardiovascular priorities, particularly during active cancer treatment, with age further limiting self-care engagement. Phas…

…ung cancer, and hepatocellular carcinoma. SLC7A7 is involved in cancer proliferation and metastasis, with a notable impact on shaping …

…on to the fragile arrangements that currently make cross-border cancer care a viable option for many Ukrainian patients. If post-confl…

…good accuracy in patients with stroke, especially in metastatic cancer.…

…aiming to prevent cancer and develop therapeutic interventions, cancer remains a formidable challenge. In view of the persistent rise …

…exhibited potent and durable anti-tumor activity. In an ovarian cancer model, adjuvant administration of uPAR CAR T cells post-surgica…